Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA)

Cancer Res. 1995 Nov 1;55(21):5043-8.

Abstract

E-cadherin is a cell to cell adhesion molecule which acts as a suppressor of metastasis. This study examined the effect of gamma-linolenic acid (GLA), a n-6 polyunsaturated fatty acid, on the expression of E-cadherin in human cancer cells. Western blotting studies demonstrated that treatment of cells with GLA for 24 h increased the expression of E-cadherin in lung, colon, breast, melanoma, and liver cancer cells, but not in endothelial cells and fibroblasts. The results were confirmed by immunocytochemistry. In contrast, two other n-6 fatty acids, linoleic acid and arachidonic acid, failed to induce these changes. The increased expression of E-cadherin was correlated with reduced in vitro invasion and increased aggregation, indicating that the increased E-cadherin expression induced by GLA was biologically active. These data add GLA to the short list of E-cadherin up-regulatory factors. The up-regulation of E-cadherin expression in human cancer cells may contribute to the anticancer properties of GLA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Arachidonic Acid / pharmacology
  • Blotting, Western
  • Cadherins / metabolism
  • Cadherins / physiology*
  • Cell Aggregation / drug effects
  • Cell Aggregation / physiology
  • Humans
  • Immunohistochemistry
  • Linoleic Acid
  • Linoleic Acids / pharmacology
  • Neoplasm Invasiveness
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Tumor Cells, Cultured / drug effects
  • gamma-Linolenic Acid / pharmacology*

Substances

  • Antineoplastic Agents
  • Cadherins
  • Linoleic Acids
  • Arachidonic Acid
  • gamma-Linolenic Acid
  • Linoleic Acid